(Q47815734)

5 February 2018

title

p53 and HLA class-I expression are not down-regulated in colorectal cancer liver metastases. (English)

1 reference

5 February 2018

1 reference

4

Hein Putter

1 reference

5 February 2018

author name string

Anand G Menon

1

1 reference

5 February 2018

Rob A E M Tollenaar

2

1 reference

5 February 2018

Cornelis J H van de Velde

3

1 reference

5 February 2018

Connie M Janssen-van Rhijn

5

1 reference

5 February 2018

Rob Keijzer

6

1 reference

5 February 2018

Gert Jan Fleuren

7

1 reference

5 February 2018

Peter J K Kuppen

8

1 reference

5 February 2018

publication date

1 January 2004

1 reference

5 February 2018

Clinical & Experimental Metastasis

published in

1 reference

5 February 2018

volume

21

1 reference

5 February 2018

page(s)

79-85

1 reference

5 February 2018

issue

1

1 reference

5 February 2018

https://scigraph.springernature.com/pub.10.1023/b:clin.0000017206.08931.42

exact match

0 references

cites work

Factors influencing the natural history of colorectal liver metastases

1 reference

12 December 2020

Induction of p53-specific immune responses in colorectal cancer patients receiving a recombinant ALVAC-p53 candidate vaccine

1 reference

12 December 2020

Loss of HLA-A,B,C and de novo expression of HLA-D in colorectal cancer

1 reference

12 December 2020

Human tumor antigens are ready to fly.

1 reference

12 December 2020

Immunohistochemical detection of p53 and Bcl-2 in colorectal carcinoma: no evidence for prognostic significance

1 reference

12 December 2020

Express yourself or die: peptides, MHC molecules, and NK cells

1 reference

12 December 2020

p53 as a target for cancer vaccines: recombinant canarypox virus vectors expressing p53 protect mice against lethal tumor cell challenge.

1 reference

12 December 2020

Frequency of abnormal expression of HLA-A,B,C and HLA-DR molecules, invariant chain, and LFA-3 (CD58) in colorectal carcinoma and its impact on tumor recurrence

1 reference

12 December 2020

Estimating the world cancer burden: Globocan 2000.

1 reference

12 December 2020

Higher expression of oncoproteins c-myc, c-erbB-2/neu, PCNA, and p53 in metastasizing colorectal cancer than in nonmetastasizing tumors

1 reference

12 December 2020

Clinical relevance of transforming growth factor alpha, epidermal growth factor receptor, p53, and Ki67 in colorectal liver metastases and corresponding primary tumors

1 reference

12 December 2020

p53 mutations in human cancers

1 reference

12 December 2020

Characterization of p53 mutations in colorectal liver metastases and correlation with clinical parameters

1 reference

12 December 2020

Influence of major histocompatibility complex class I and II antigens on survival in colorectal carcinoma.

1 reference

12 December 2020

Expression of HLA-A,B,C antigens on primary and metastatic tumor cell populations of human carcinomas

1 reference

12 December 2020

Levamisole and fluorouracil for adjuvant therapy of resected colon carcinoma

1 reference

12 December 2020

Randomised trial of monoclonal antibody for adjuvant therapy of resected Dukes' C colorectal carcinoma. German Cancer Aid 17-1A Study Group

1 reference

12 December 2020

HLA expression in uveal melanoma: there is no rule without some exception

1 reference

12 December 2020

Specificity of seven monoclonal antibodies against p53 evaluated with Western blotting, immunohistochemistry, confocal laser scanning microscopy, and flow cytometry

1 reference

12 December 2020

Recommendation for caution with irinotecan, fluorouracil, and leucovorin for colorectal cancer

1 reference

12 December 2020

Active specific immunotherapy for stage II and stage III human colon cancer: a randomised trial

1 reference

12 December 2020

P53 mutations in primary tumors and subsequent liver metastases are related to survival in patients with colorectal carcinoma who undergo liver resection

1 reference

12 December 2020

p53 nuclear protein overexpression in colorectal cancer: a dominant predictor of survival in patients with advanced hepatic metastases

1 reference

12 December 2020

HLA-A- and HLA-B-specific monoclonal antibodies reactive with free heavy chains in western blots, in formalin-fixed, paraffin-embedded tissue sections and in cryo-immuno-electron microscopy

1 reference

12 December 2020

P53 overexpression in colorectal metastases confined to the liver and outcome of liver resection

1 reference

12 December 2020

p53 mutations in primary colorectal adenocarcinomas and liver metastases

1 reference

12 December 2020

Increased incidence of p53 mutations is associated with hepatic metastasis in colorectal neoplastic progression.

1 reference

12 December 2020

Down-regulation of HLA-A expression correlates with a better prognosis in colorectal cancer patients

1 reference

12 December 2020

Phenotypic expression of histocompatibility antigens in human primary tumours and metastases

1 reference

12 December 2020

Tumor eradication by wild-type p53-specific cytotoxic T lymphocytes.

1 reference

12 December 2020

Reduced expression of HLA class I and II antigens in colon cancer

1 reference

12 December 2020

Cell proliferation-related markers in colorectal liver metastases: correlation with patient prognosis

1 reference

12 December 2020

HLA class I gene expression on human primary tumours and autologous metastases: demonstration of selective losses of HLA antigens on colorectal, gastric and laryngeal carcinomas

1 reference

12 December 2020

10.1023/B:CLIN.0000017206.08931.42

Identifiers

DOI

1 reference

5 February 2018

Dimensions Publication ID

0 references

1 reference

5 February 2018